Farmaci

May 23, 2026, 7:27 AM EDT. IperionX Limited has commissioned a 300-ton SACMI powder metallurgy press at its South Boston, Virginia campus, tripling its U.S. titanium manufacturing capacity. This expansion supports integration with advanced sintering and forging technologies under a U.S. government-backed program aimed at reshoring critical titanium supply chains for defense and aerospace sectors. While the upgrade moves IperionX closer to initial production and potential increased orders from the Department of Defense and industrial customers, the company continues to report zero revenue, rising losses, and a short cash runway. Market valuations vary widely amid execution and funding risks, making investor perspectives on growth prospects divergent. The stock's recent price decline may present value opportunities but requires careful risk assessment given its current financial position.